Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertram Pitt

Showing results (111-120 of 687) with videos related to

Pageof 69
Sort By:
European Heart Journal|February 19, 2010
Depression and cardiovascular disease: have a happy day--just smile!Bertram Pitt, Patricia J Deldin
The American Journal of Cardiology|May 16, 2006
Role of aldosterone blockade for treatment of heart failure and post-acute myocardial infarctionBarry Greenberg, Faiez Zannad, Bertram Pitt
Expert Opinion on Investigational Drugs|October 1, 2021
An evaluation of KBP-5074 in advanced chronic kidney disease with uncontrolled hypertensionBertram Pitt, Frederic Jaisser, George Bakris
Clinical Trials (London, England)|November 18, 2018
Beware of on-treatment safety analysesFred Yang, Janet Wittes, Bertram Pitt
The American Journal of Cardiology|October 3, 2002
Coronary angiographic changes in patients with cardiac events in the Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT)G B John Mancini, Bertram Pitt
European Journal of Heart Failure|June 9, 2018
Need to revisit heart failure treatment guidelines for hyperkalaemia management during the use of mineralocorticoid receptor antagonistsJaved Butler, Shilpa Vijayakumar, Bertram Pitt
European Heart Journal|February 6, 2024
Mineralocorticoid receptor antagonists for the prevention of atrial fibrillation in patients with and without heart failure: one more beneficial effect?Daniela Zurkan, Bertram Pitt, Frank Edelmann
The New England Journal of Medicine|April 20, 2022
Cardiovascular Events with Finerenone in CKD and Diabetes. ReplyBertram Pitt, Amer Joseph, Patrick Schloemer
European Heart Journal|June 16, 2011
Mineralocorticoid receptor antagonism: therapeutic potential in acute heart failure syndromesMazen Albaghdadi, Mihai Gheorghiade, Bertram Pitt
International Journal of Cardiology|December 4, 2014
Time to retrieve the best benefits from renin angiotensin aldosterone system (RAAS) inhibition in heart failure patients with reduced ejection fraction: lessons from randomized controlled trials and registriesPatrick Rossignol, Faiez Zannad, Bertram Pitt, et al.
Pageof 69

Showing results (111-120 of 687) with videos related to

Sort By:
Pageof 69
European Heart Journal|February 19, 2010
Depression and cardiovascular disease: have a happy day--just smile!Bertram Pitt, Patricia J Deldin
The American Journal of Cardiology|May 16, 2006
Role of aldosterone blockade for treatment of heart failure and post-acute myocardial infarctionBarry Greenberg, Faiez Zannad, Bertram Pitt
Expert Opinion on Investigational Drugs|October 1, 2021
An evaluation of KBP-5074 in advanced chronic kidney disease with uncontrolled hypertensionBertram Pitt, Frederic Jaisser, George Bakris
Clinical Trials (London, England)|November 18, 2018
Beware of on-treatment safety analysesFred Yang, Janet Wittes, Bertram Pitt
The American Journal of Cardiology|October 3, 2002
Coronary angiographic changes in patients with cardiac events in the Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT)G B John Mancini, Bertram Pitt
European Journal of Heart Failure|June 9, 2018
Need to revisit heart failure treatment guidelines for hyperkalaemia management during the use of mineralocorticoid receptor antagonistsJaved Butler, Shilpa Vijayakumar, Bertram Pitt
European Heart Journal|February 6, 2024
Mineralocorticoid receptor antagonists for the prevention of atrial fibrillation in patients with and without heart failure: one more beneficial effect?Daniela Zurkan, Bertram Pitt, Frank Edelmann
The New England Journal of Medicine|April 20, 2022
Cardiovascular Events with Finerenone in CKD and Diabetes. ReplyBertram Pitt, Amer Joseph, Patrick Schloemer
European Heart Journal|June 16, 2011
Mineralocorticoid receptor antagonism: therapeutic potential in acute heart failure syndromesMazen Albaghdadi, Mihai Gheorghiade, Bertram Pitt
International Journal of Cardiology|December 4, 2014
Time to retrieve the best benefits from renin angiotensin aldosterone system (RAAS) inhibition in heart failure patients with reduced ejection fraction: lessons from randomized controlled trials and registriesPatrick Rossignol, Faiez Zannad, Bertram Pitt, et al.
Pageof 69